WATCH LIVE Long Covid is more common among women than men, according to federal data. More than 17% of women have had long Covid at some point during the pandemic, compared with 11% of men, according to data from U.S. Census Bureau and National Center […]
Month: October 2022
We’re exiting a drug stock for a nice gain and putting some of that money to work elsewhere
We’re exiting our position in AbbVie (ABBV), selling 300 shares at roughly $148.14 each. We’re also buying 75 shares of Starbucks (SBUX) at roughly $85.93 each. Following Friday’s trades, Jim’s Charitable Trust will no longer own a position in AbbVie and will own 750 shares […]
Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S.
Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S., a significant jump from […]
Multiple revenue misses in one of our winners convinced us to take profits and get out
AbbVie (ABBV) reported a mixed second-quarter Friday morning. Despite a pullback in shares after the release, we decided to lock-in a great 61% return and exit a stock that has been one of this year’s winners. We never like to sell on a down day, but […]
FDA says two studies showing omicron boosters weren’t much better than old Covid shots were too small to come to any conclusions
The Food and Drug Administration said two studies this week showing that the new omicron boosters weren’t that much better than the old shots were too small to come to any real conclusions. Scientists at Columbia and Harvard, in two independent studies, found the new […]
Covid cases, controls spread in China
WATCH LIVE BEIJING — Covid controls in China have tightened in the last two weeks after more cities reported virus outbreaks. The restrictions on business and social activity affected 9.2% of China’s gross domestic product as of Thursday, up from 7% on Oct. 16, according […]
New Covid boosters aren’t better than old shots at neutralizing omicron BA.5, early studies find
Two studies are raising doubts about whether the new omicron BA.5 booster really will offer better protection against Covid than the first generation shot. Scientists at Columbia University in New York City found the new boosters did not produce a better antibody response in humans […]
Omicron subvariants are resistant to key antibody treatments, putting people with weak immune systems at risk of Covid
Emerging omicron subvariants are resistant to key antibody treatments for HIV patients, kidney transplant recipients and other immunocompromised people, making them particularly vulnerable to Covid this winter, the White House warned this week. “With some of the new subvariants that are emerging, some of the […]
Deutsche Bank upgrades Humana for the same reasons we own this big 2022 winner
Club holding Humana (HUM) got an upgrade on Wall Street on Wednesday, exactly one week before the health insurer reports earnings. Deutsche Bank took Humana to a buy rating from a hold, citing its “leading position in Medicare Advantage,” a key reason we own the […]
Maven Clinic, women and family-focused health startup, is booming in the post-Roe v. Wade world
Women account for half of consumers, hold power over 80% of household financial decisions and make 70% of health-care-related decisions in their families – but their access to proper health care often comes up short. Especially in the post-Roe world, women are increasingly turning to […]